Summary
- Current Price
- As of today, NAGE price is $3.43, up +3.00% on
- Current Price All-Time High
- NAGE price is currently -85.50% below its historical high of $23.66 set on
- Market Cap
- NAGE current market cap is $273M, down -72.71% year-over-year
- PE Ratio
- NAGE current PE ratio is 15.72
- Revenue
- NAGE current annual revenue is $129.42M, up +29.95% year-over-year
- Next Earnings
- The next earnings release for NAGE is on
Profile
| Metric | Value |
|---|---|
| Full Name | Niagen Bioscience, Inc. |
| Ticker | NASDAQ: NAGE |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | niagenbioscience.com |
| Employees | 104 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $3.43 | |
| Price, 1D Change | +3.00% | |
| $273M | ||
| - | ||
| 15.72 | ||
| 1.27 | ||
| $129M | ||
| Revenue, 1Y Change | +29.95% | |
| $0.20 | ||
| EPS, 1Y Change | +85.92% |
Chart
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:3 | |
| Next Split | N/A | N/A |
| Last Ticker Change | CDXC | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| $0.20 | ||
| EPS Estimate | N/A | $0.23 |
| EPS Est. Change | N/A | +13.08% |
| $129.42M | ||
| Revenue Estimate | N/A | $142.28M |
| Revenue Est. Change | N/A | +9.94% |
| Current Price | $3.43 | |
| Price Target | - | $12.00 |
| Price Tgt. Change | - | +249.85% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.11 | - | |
| $0.18 | $0.20 | +13.00% | |
| $0.23 | N/A | +13.08% | |
| $0.31 | N/A | +49.95% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $99.60M | - | |
| $127.29M | $129.42M | +1.67% | |
| $142.28M | N/A | +9.94% | |
| $166.92M | N/A | +28.97% |
🔒 Log In To Unlock Full Data
Performance
Technicals
| Metric | Date | Value |
|---|---|---|
| Current Price | $3.43 | |
| $5.70 | ||
| $3.87 | ||
| $5.39 | ||
| $3.80 | ||
| -$0.13 | ||
| 1.27 | ||
| $0.16 | ||
| 46.22 | ||
| 54.28% | ||
| 49.64% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $129.42M | ||
| $0.20 | ||
| $83.19M | ||
| 64.28% | ||
| $14.30M | ||
| 11.05% | ||
| $17.38M | ||
| 13.43% | ||
| $15.75M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.04 | ||
| 4.86 | ||
| 3.83 | ||
| - | ||
| 6 | ||
| 5.85 |
Valuations
| Metric | Date | Value |
|---|---|---|
| 15.72 | ||
| 2.09 | ||
| 3.32 | ||
| 16.54 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $76.53M | ||
| $64.79M | ||
| $106.41M | ||
| $96.81M | ||
| $29.87M | ||
| $19.92M | ||
| $2.82M | ||
| $1.00M | ||
| $10.80M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $112.04M | ||
| $68.89M | ||
| $46.23M | ||
| $0.00 | ||
| $1.45M | ||
| $0.00 | ||
| $810.00K |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| $13.44M | ||
| -$292.00K | ||
| $6.98M | ||
| $292.00K | ||
| $13.15M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| HC Wainwright & Co. | → | |
| Canaccord Genuity | → | |
| Canaccord Genuity | → | |
| Canaccord Genuity | → | |
| Canaccord Genuity | → | |
| HC Wainwright & Co. | → | |
| Canaccord Genuity | → | |
| Roth Capital | → | |
| Canaccord Genuity | ||
| HC Wainwright & Co. | → |
Analyst sentiment
Institutional ownership
Screeners with NAGE
FAQ
What is the ticker symbol for Niagen Bioscience, Inc.?
The ticker symbol for Niagen Bioscience, Inc. is NASDAQ:NAGE
Does Niagen Bioscience, Inc. pay dividends?
No, Niagen Bioscience, Inc. does not pay dividends
What sector is Niagen Bioscience, Inc. in?
Niagen Bioscience, Inc. is in the Healthcare sector
What industry is Niagen Bioscience, Inc. in?
Niagen Bioscience, Inc. is in the Biotechnology industry
What country is Niagen Bioscience, Inc. based in?
Niagen Bioscience, Inc. is headquartered in United States
When did Niagen Bioscience, Inc. go public?
Niagen Bioscience, Inc. initial public offering (IPO) was on June 24, 2015
Is Niagen Bioscience, Inc. in the S&P 500?
No, Niagen Bioscience, Inc. is not included in the S&P 500 index
Is Niagen Bioscience, Inc. in the NASDAQ 100?
No, Niagen Bioscience, Inc. is not included in the NASDAQ 100 index
Is Niagen Bioscience, Inc. in the Dow Jones?
No, Niagen Bioscience, Inc. is not included in the Dow Jones index
When was Niagen Bioscience, Inc. last earnings report?
Niagen Bioscience, Inc.'s most recent earnings report was on May 6, 2026
When does Niagen Bioscience, Inc. report earnings?
The next expected earnings date for Niagen Bioscience, Inc. is August 5, 2026
Data Sources & References
- NAGE Official Website www.niagenbioscience.com
- NAGE Profile on Yahoo Finance finance.yahoo.com/quote/NAGE
- NAGE Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/nage